TD Asset Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$279 Hold
34,884
﹤0.01% 1230
2025
Q4
$1.65K Hold
34,884
﹤0.01% 1232
2025
Q3
$3.82K Hold
34,884
﹤0.01% 1234
2025
Q2
$2.3K Hold
34,884
﹤0.01% 1192
2025
Q1
$7.33K Hold
34,884
﹤0.01% 1214
2024
Q4
$5.58K Hold
34,884
﹤0.01% 1241
2024
Q3
$2.41K Hold
34,884
﹤0.01% 1383
2024
Q2
$1.04K Hold
34,884
﹤0.01% 1360
2024
Q1
$1.92K Hold
34,884
﹤0.01% 1379
2023
Q4
$415 Hold
34,884
﹤0.01% 1388
2023
Q3
$1.04K Buy
34,884
+17,442
+100% +$485 ﹤0.01% 1407
2023
Q2
$124 Hold
17,442
﹤0.01% 1410
2023
Q1
$323 Hold
17,442
﹤0.01% 1427
2022
Q4
$331 Hold
17,442
﹤0.01% 1444
2022
Q3
$3K Hold
17,442
﹤0.01% 1470
2022
Q2
$6K Hold
17,442
﹤0.01% 1452
2022
Q1
$12K Hold
17,442
﹤0.01% 1478
2021
Q4
$17K Hold
17,442
﹤0.01% 1489
2021
Q3
$37K Buy
+17,442
New +$57.3K ﹤0.01% 1515

Other funds holding WGSWW

TD Asset Management's WGSWW Position: Q1 2026 in Review

TD Asset Management held its GeneDx Holdings Warrant (WGSWW) position steady in Q1 2026 at 34,884 shares worth $279. The position accounts for ﹤0.01% of the portfolio, ranked #1230.

TD Asset Management first reported a position in WGSWW in Q3 2021 and has held it in 19 quarters since. The position peaked at $37K in Q3 2021. 13 funds tracked by Wall St. Rank hold WGSWW as of Q1 2026.

  • TD Asset Management held 34,884 shares of GeneDx Holdings Warrant worth $279 as of Q1 2026.
  • TD Asset Management left its GeneDx Holdings Warrant share count unchanged in Q1 2026.
  • GeneDx Holdings Warrant made up ﹤0.01% of TD Asset Management's portfolio in Q1 2026, its #1230 holding.
  • TD Asset Management first reported a position in GeneDx Holdings Warrant in Q3 2021 and has held it in 19 quarters since.
  • TD Asset Management's GeneDx Holdings Warrant position peaked at $37K in Q3 2021.
  • 13 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.